Bruker Q4 2020 Earnings Report
Key Takeaways
Bruker Corporation reported a 4.6% increase in revenue for Q4 2020, reaching $627.5 million. GAAP EPS was $0.45, while non-GAAP EPS increased by 9.4% to $0.58. The company experienced growth in non-GAAP operating income and margin, driven by strong gross margin performance and expense control.
Q4 2020 revenues increased by 4.6% year-over-year to $627.5 million.
Organic revenue declined slightly by 0.4% year-over-year.
Non-GAAP operating margin increased by 40 basis points to 22.5%.
Non-GAAP diluted EPS increased by 9.4% to $0.58.
Bruker
Bruker
Bruker Revenue by Segment
Forward Guidance
Bruker expects approximately 11% to 13% year-over-year revenue growth for FY 2021. Non-GAAP operating margin expansion of 150 bps to 190 bps year-over-year is expected. Finally, Bruker expects FY 2021 non-GAAP EPS of $1.72 to $1.77, a 27% to 31% increase year-over-year.
Positive Outlook
- Approximately 11% to 13% year-over-year revenue growth
- Non-GAAP operating margin expansion of 150 bps to 190 bps year-over-year
- FY 2021 non-GAAP EPS of $1.72 to $1.77
- 27% to 31% increase year-over-year in non-GAAP EPS
- Based on foreign exchange rates as of December 31, 2020
Challenges Ahead
- Accelerated R&D investments of approximately 10% of revenue
- Headwind from foreign currency translation to operating margin of approximately 80 basis points in 2021
- Unable to provide without unreasonable effort the most directly comparable GAAP financial measures
- Excludes primarily the future impact of restructuring actions
- Excludes unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments